Showing results (11-20 of 27) with videos related to
Sort By:
Pageof 3
Journal of Applied Clinical Medical Physics|March 30, 2023
In-vivo quality assurance of dynamic tumor tracking (DTT) for liver SABR using EPID imagesMaryam Rostamzadeh, Kurt Luchka, Roy Ma, et al.Clinical and Translational Radiation Oncology|September 6, 2019
Cardiac death after breast radiotherapy and the QUANTEC cardiac guidelinesLaura Beaton, Alanah Bergman, Alan Nichol, et al.Journal of Applied Clinical Medical Physics|October 4, 2023
Markerless dynamic tumor tracking (MDTT) radiotherapy using diaphragm as a surrogate for liver targetsMaryam Rostamzadeh, Steven Thomas, Marie-Laure Camborde, et al.Journal of Applied Clinical Medical Physics|June 23, 2021
Development of a physical geometric phantom for deformable image registration credentialing of radiotherapy centers for a clinical trialNoriyuki Kadoya, Siwaporn Sakulsingharoj, Tomas Kron, et al.International Journal of Radiation Oncology, Biology, Physics|December 19, 2015
Volumetric Radiosurgery for 1 to 10 Brain Metastases: A Multicenter, Single-Arm, Phase 2 StudyAlan Nichol, Roy Ma, Fred Hsu, et al.International Journal of Radiation Oncology, Biology, Physics|August 28, 2021
Thecal Sac Contouring as a Surrogate for the Cauda Equina and Intracanal Spinal Nerve Roots for Spine Stereotactic Body Radiation Therapy (SBRT): Contour Variability and Recommendations for Safe PracticeEmma M Dunne, Simon S Lo, Mitchell C Liu, et al.International Journal of Radiation Oncology, Biology, Physics|February 9, 2025
The Impact of Ultracentral Tumor Location on Outcomes in Patients with Pulmonary Oligometastases: A Secondary Analysis of the Single-Arm Phase 2 SABR-5 TrialSarah Baker, Curtis Leclerc, Hanna Atmanspacher-Wirth, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 25, 2019
International consensus recommendations for target volume delineation specific to sacral metastases and spinal stereotactic body radiation therapy (SBRT)Emma M Dunne, Arjun Sahgal, Simon S Lo, et al.BMC Cancer|October 6, 2018
Population-based phase II trial of stereotactic ablative radiotherapy (SABR) for up to 5 oligometastases: SABR-5Robert Olson, Mitchell Liu, Alanah Bergman, et al.International Journal of Radiation Oncology, Biology, Physics|January 15, 2022
Determining Planning Priorities for SABR for Oligometastatic Disease: A Secondary Analysis of the SABR-COMET Phase II Randomized TrialMatthew Van Oirschot, Alanah Bergman, Wilko F A R Verbakel, et al.Pageof 3